Determinants of generic drug substitution in the Czech Republic
|Author:||Mgr. Pavlína Žílová|
|Year:||2015 - summer|
|Leaders:|| PhDr. Jana Votápková Ph.D.
|Work type:|| Finance, Financial Markets and Banking
|Awards and prizes:|
|Abstract:||This study uses logistic regression to estimate the probability of choosing the brand-name
drug despite the presence of cheaper generics given patient and drug characteristics in the
Czech pharmaceutical market in the period 2009-2013. Results of the analysis may help guide
policies to decrease pharmaceutical costs. In order to motivate people who are more likely to
choose the original version of drug, policy makers may impose higher copayments and lower
subsidies on the original drugs which they use. Additionally, two supplementary analyses
were applied to sub-sectors of the pharmaceutical market: antihypertensive drugs and
antibiotics. Fixed effects logistic regression is employed to test the robustness of the results.